Vonjo

pacritinib

Approval

ApplicationNDA 208712
Approval dateFeb 28, 2022
Approval year2022
SponsorSobi

FDA-approved use

To treat intermediate or high-risk primary or secondary myelofibrosis in adults with low platelets

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Vonjo: